Lead Product(s): ChAdOx1 nCoV-19
Therapeutic Area: Infections and Infectious Diseases
Highest Development Status: Phase I/ Phase II Product Type: Vaccine
Partner/Sponsor/Collaborator: University’s Jenner Institute
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration April 15, 2020
Under the collaboration, Halix will utilise its brand new state-of-the-art GMP facilities with capacity up to 1,000 L SUB scale, supporting the manufacture of ChAdOx1 nCoV-19 clinical trial material.